October 31, 2017
Actelion to be delisted from SIX Swiss Exchange in November
Actelion said on Tuesday that, by decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: shares
October 25, 2017
Ablynx prices $200M public offering, trades on NASDAQ
Belgian Ablynx on Wednesday announced the pricing of its initial U.S. public offering totaling $200 million, from 11,430,000 American Depositary…
January 25, 2017
TXCell needs €11M by issuing new shares, covers next year’s requirements
TxCell has moved into action to raise some money, as it wants to raise gross proceeds of about €11 million by issuing new shares with warrants attached.
January 9, 2017
Takeda notifies 4.48% shareholding in TiGenix
On January 4, 2017, TiGenix received a transparency notification from related companies Takeda Pharmaceutical Company Limited/Takeda Pharmaceuticals International AG, following…
December 13, 2016
Short: Active Biotech’s rights issue completed
Active Biotech has announced on Tuesday that following the end of the subscription period, the results of Active Biotech’s rights issue…
December 8, 2016
Erytech places shares, funds acute leukemia drug
Acute leukemia focused pharmaceutical company Erytech Pharma, has announced the closing of a private placement of 793,877 ordinary shares to…
December 8, 2016
Hair care company places shares, raises half million
InnovaDerma, a UK -based company focused on hair loss, hair care, self-tanning and skin rejuvenation, has raised £539,999.60 through the…
November 16, 2015
Horizon Pharma shareholders approve issuance of ordinary shares in connection with acquisition of Depomed
Dublin-based Horizon Pharma has provided an update on shareholders meeting related to the proposed acquisition of Depomed, Inc., according to which shareholders approved the issuance of up to 81,706,881 ordinary shares of Horizon Pharma plc, in connection with an acquisition of Depomed, Inc.